Skip to main content

Ortho Clinical Diagnostics Receives $678K BARDA Grant for SARS-CoV-2 Antibody Tests

NEW YORK – Ortho Clinical Diagnostics announced Wednesday it has received a $678,000 grant from the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority to support its SARS-CoV-2 antibody tests.

Ortho offers a total antibody test detecting IgA, IgM, and IgG antibodies and a test specifically for IgG antibodies, which remain elevated even after a patient recovers from COVID-19. Raritan, New Jersey-based Ortho said it can process up to 150 total antibody tests per hour. Both tests received Emergency Use Authorization from the US Food and Drug Administration in April.

The tests run on Ortho's Vitros XT 7600 Integrated System, Vitros 3600 Immunodiagnostic System, Vitros 5600 Integrated System, and Vitros ECi/ECiQ Immunodiagnostic Systems. There are currently more than 5,600 instruments installed globally, with more than 1,000 placed in the US. Ortho said in a statement it is producing millions of tests each week.